Phase I clinical trial using peptide vaccine for human vascular endothelia 1 growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer.
書誌事項
- タイトル
- Phase I clinical trial using peptide vaccine for human vascular endothelia 1 growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer.
- 著者
- Miyazawa M
収録刊行物
-
- Cancer Sci.
-
Cancer Sci. 101(2) 433-9, 2010